|
⚲
|
| Keyboard |
| Miyashita Akiko Moni
✚
|
|
|---|---|
| CIK # | 0001607742 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001607742] | |
| 4 | [0001607742] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Averin Capital Acquisition Corp | |
| Miyashita Akiko Moni | |
| Halozyme Therapeutics Inc | |
| Emmaus Life Sciences Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2025-05-01 | Grant | 4,165 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2025-05-01 | Grant | 5,750 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2024-04-25 | Grant | 6,501 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2024-04-25 | Grant | 8,804 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Common Stock
|
2023-05-05 | Grant | 8,065 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Option to Purchase Common Stock · derivative
|
2023-05-05 | Grant | 11,371 | $0.00 | |
|
Halozyme Therapeutics Inc HALO
Restricted Stock Units
|
2022-05-05 | Grant | 6,206 | $0.00 | |
|
Emmaus Life Sciences Inc NONE
Non-Qualified Stock Options · derivative
|
2014-05-08 | Grant | 102,000 | $0.00 |